WO1998026865A1 - Encapsulation - Google Patents

Encapsulation Download PDF

Info

Publication number
WO1998026865A1
WO1998026865A1 PCT/GB1997/003346 GB9703346W WO9826865A1 WO 1998026865 A1 WO1998026865 A1 WO 1998026865A1 GB 9703346 W GB9703346 W GB 9703346W WO 9826865 A1 WO9826865 A1 WO 9826865A1
Authority
WO
WIPO (PCT)
Prior art keywords
encapsulent
acid
mixture
colloidal aggregate
resin
Prior art date
Application number
PCT/GB1997/003346
Other languages
French (fr)
Inventor
Dennis William Quinn
Alexander Martin Thompstone
Original Assignee
Chemcolloids Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemcolloids Limited filed Critical Chemcolloids Limited
Priority to EP97949004A priority Critical patent/EP0948397A1/en
Priority to CA002275377A priority patent/CA2275377A1/en
Priority to AU77366/98A priority patent/AU727915B2/en
Priority to JP52742798A priority patent/JP2001507051A/en
Publication of WO1998026865A1 publication Critical patent/WO1998026865A1/en
Priority to NO992932A priority patent/NO992932L/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/025Applications of microcapsules not provided for in other subclasses

Definitions

  • the present invention relates to microcapsuies of acid and to
  • the invention is a
  • thermoset resin applications use heat to cure
  • the resin is mixed with its catalyst and is used for the specific
  • microcapsuies are so small they can
  • One particular class of resin is that of phenolic resins which are
  • aldehydes typically formaldehyde
  • thermoset resin industry using phenolic resin systems for the thermoset resin industry is that
  • the resin initially comprises a low molecular weight fusible solid resin
  • Phenolic resins are usually initiated/catalysed by the addition
  • An object of this invention is to provide capsules of strong
  • the present invention also seeks to provide
  • thermoset resin industry makes it particularly suitable for use in the thermoset resin industry.
  • colloidal aggregate suitable for use in the curing of resins
  • the continuous phase may be ruptured by an external energy source
  • the encapsulent comprises a water based acid
  • the strong acid may comprise sulphuric acid, hydrochloric
  • system comprises resin and a dispersed catalyst/initiator said catalyst/initiator being colloidal aggregate comprising a continuous
  • the invention has a general application in that a resin
  • the fibrous layer can be shaped to any desired shape, such as
  • the resin can be cured for example by the application heat or
  • the resin/colloidal capsule carrier material preferably has a
  • fibrous sheet structure including a mat, a web or randomly orientated
  • fibres and the fibres may be of glass and/or of natural and synthetic
  • reactive radicals in particular H « and OH* are ultrasonically produced from water and react with molecular oxygen present in the
  • preparations of this invention comprises a collimated 20 Khz beam
  • An amplifying horn preferably in an atmosphere of argon.
  • made of titanium may be fixed adjacent to the transducer for
  • the sonication cell is preferably retained in
  • Audible sound may also be used.
  • the capsules formed in the sonification step are heated for a period
  • the curing of phenolic resin is generally initiated/catalysed by
  • aqueous medium and were of a sizes less than 100 advantageously
  • capsules 2 are dispersed in water and comprise an
  • capsules with particle sizes of less than 100 microns advantageously
  • the gelatin/water/acid colloid was heated in an oven at 60° for
  • gelatin capsules of the present invention It has been found that gelatin capsules of the present invention
  • the encapsulation material may take many different forms.
  • a material comprising a combination of gelatin
  • an external energy source such as ultrasound.
  • the material is produced by the adhesion, agglomeration and
  • ingredient combinations may also be used:-
  • PGA Propylene Glycol Alginate
  • Pectins - are the partial breakdown products of complex structures in plant cell wall (normally fruits). These can
  • the capsules of acid may be mixed with the resin to be cured
  • the resins may be phenolic or urea
  • the mixing process is low energy, low shear to avoid
  • a suitable form of mixer may
  • cured and encapsulated acid may be tailored to a customer's
  • the capsules dispersed in the resin may be ruptured to release

Abstract

A colloidal aggregate suitable for use in the curing of resins comprises a continuous phase of a water based encapsulent material and a dispersed phase comprising one or more strong acids. The continuous phase advantageously comprises a mixture of gelatin and xanthan gum. The aggregate is sonicated to encapsulate the acid in the encapsulent material. The encapsulated acid is mixed with a curable resin. The acid capsules may be ruptured by any suitable means, but particularly ultrasound, to release the acid to initiate curing of the resin.

Description

ENCAPSULATION
The present invention relates to microcapsuies of acid and to
apparatus for and method of their production. The invention is
particularly, but not exclusively concerned with microcapsuies of
catalysts and/or initiators used in the curing of synthetic resins.
In the majority of uses, the processing and curing of resins is
carried out under controlled conditions. However, circumstances
occur when it is necessary to control/prevent the curing of a resin
before an appropriate time in order to attain the best utilisation of the resin.
The majority of thermoset resin applications use heat to cure
the resin, the application of heat causing a catalyst and/or promoter
in the resin to accelerate the cross-linking of resin molecules.
However, even if heat is not applied, the resin will cure over a period
of days, thereby restricting the time during which uncured resin can
be stored. Therefore, from the above it can be seen that as soon as
the resin is mixed with its catalyst and is used for the specific
application there is a race against time to get the resin/catalyst
system in place.
The industry is aware of this problem and some attempts have been made to solve it by developing special resins which are curable
by light radiation.
Ultra small microcapsuies of the order of less than 100 micron
diameter, are formed which are of appropriate size to be used in
thermoset applications when such microcapsuies are dispersed
throughout the resin. When the microcapsuies are so small they can
be uniformly dispersed and will not settle out in the resin.
One particular class of resin is that of phenolic resins which are
the products of reactions between phenols (commonly phenol) and
aldehydes (typically formaldehyde). One of the main advantages of
using phenolic resin systems for the thermoset resin industry is that
the resin initially comprises a low molecular weight fusible solid resin
that may be easily handled and subsequently, upon curing, forms a
high molecular weight, strong, heat resistant material.
Phenolic resins are usually initiated/catalysed by the addition
of strong acids such as sulphuric acid, hydrochloric acid, phosphoric
acid, Toluenesulphonic acid and the like, all of which are extremely
corrosive and difficult to handle. The corrosive nature of the acids is
one of the main factors which have made them exceptionally difficult
to encapsulate and without some form of encapsulation or controlled
release it is impossible to control the release of the acid into the resin. Another class of resins is urea formaldehyde is also of interest.
An object of this invention is to provide capsules of strong
acids which are readily dispersable in resin material without acid
leakage.
Furthermore, the present invention also seeks to provide
curable resin systems for the production of rigid articles wherein the
resin can be cured readily and quickly, but retains a long shelf life
making it particularly suitable for use in the thermoset resin industry.
According to one aspect of the present invention there is
provided a colloidal aggregate suitable for use in the curing of resins
comprising a continuous phase of a water based encapsulent material
and a dispersed phase comprising one or more strong acids wherein
the continuous phase may be ruptured by an external energy source
to release the acid.
Preferably the encapsulent comprises a water based acid
resistant gelatin.
The strong acid may comprise sulphuric acid, hydrochloric
acid, phosphoric acid and toluene sulphonic acid or a mixture thereof.
According to another aspect of the invention there is provided
a resin system for the production of rigid articles wherein said resin
system comprises resin and a dispersed catalyst/initiator said catalyst/initiator being colloidal aggregate comprising a continuous
phase of a water based encapsulent material and a dispersed phase
comprising one or more strong acids wherein the continuous phase
may be ruptured by an external energy source to release the acid into
the resin and thereby initiating/catalysing the resin curing.
One advantage of this type of encapsulation over the prior art
is the fact that previously the encapsulated reactant was produced
in the form of dry capsules which were often poorly dispersed when
mixed in with resin, whereas the colloidal aggregates of the present
invention are readily dispersed ensuring intimate dispersion in the
resin and significantly reducing the likelihood of the presence of large
conglomerates of capsules.
The invention has a general application in that a resin
impregnated absorbent material with the dispersed colloidal capsules
therein can be shaped to a final form and the colloidal capsules
ruptured, for example by heating or electromagnetic energy, to
release the catalyst or promotes, to cause curing of the resin and
absorbent material in said final form.
In one embodiment of the present invention the encapsulated
catalyst is admixed with the curable resinous material which is then
used to impregnate a fibrous carrier layer. The fibrous layer can be shaped to any desired shape, such as
a boat or moulded part for a vehicle whilst the resin is uncured, and
then the resin can be cured for example by the application heat or
electromagnetic energy to rupture the colloidal capsules.
The resin/colloidal capsule carrier material preferably has a
fibrous sheet structure including a mat, a web or randomly orientated
fibres and the fibres may be of glass and/or of natural and synthetic
origin.
According to a still further aspect of the present invention
there is also provided a method for the microencapsulation of one or
more strong acids suitable for use as catalysts, promoters or initiators
in resin curing reactions, comprising the following steps :-
mixing the acid(s), a water based encapsulent and water,
sonicating the mixture so formed to encapsulate the acid(s) in
the encapsulent, and
substantially removing surplus water from the mixture to form
a colloidal aggregate of the acid in the encapsulent.
By way of a specific example when acid resistant gelatin is
used application of ultrasonic energy or gelatin in the sonicating step
causes free-radical induced cross-linking of protein molecules. Highly
reactive radicals in particular H« and OH* are ultrasonically produced from water and react with molecular oxygen present in the
solution/air to form a superoxide HO2.). Superoxide reacts with
protein molecules to produce disulphuric bonding usually between
cysteine residues. Ultrasound can produce a high concentration of
proteinaceous colloidal capsules with narrow size distributions,
generally in region of 1-20 microns.
A typical ultrasonic reactor apparatus for use in the
preparations of this invention comprises a collimated 20 Khz beam
from a lead zirconate titanate transducer and the reaction may be
carried out in a glass sonication cell in an inert atmosphere,
preferably in an atmosphere of argon. An amplifying horn, preferably
made of titanium may be fixed adjacent to the transducer for
amplification of the signal thereof. Because of temperature rises due
to the reaction processes the sonication cell is preferably retained in
a water bath. Audible sound may also be used.
Preferably in the water removal step, the aqueous mixture of
the capsules formed in the sonification step are heated for a period
of about 24 hours at a temperature below the rupture temperature of
around 80° and is preferably heated between 60 and 70°.
The present invention will be better understood by way of the
following examples which describe the encapsulation of strong acids in water based encapsulents for use as catalysts/initiators for
polymerisation reactions.
Example 1
The curing of phenolic resin is generally initiated/catalysed by
the addition of strong acids and the reaction proceeds at ambient
temperature.
In this example the curing agent which was encapsulated was
a propriety blend of phosphoric and toluene sulphonic acids.
One part by weight of the acid mixture was mixed with 3 parts
by weight of food grade gelatin (200 Bloom) dispersed in 3 parts of
water.
This mixture was sonicated for a period of three minutes
(power 100W) using a 20 Khz probe. The high intensity ultrasound
produced intermediate proteinaceous capsules in a substantially
aqueous medium and were of a sizes less than 100 advantageously
microns wherein capsules 2 are dispersed in water and comprise an
outer layer of gelatin 4 encapsulating a strong acid core 6.
It was found however that because acid mixture contained
strong acids, a gel/water boundary developed around the acid
catalyst leading to diffusion of the acid through the shell. It would
seem that is because the water present in and around each capsule shell acts as a carrier for the acid.
It was subsequently found that an improved encapsulated
product was prepared by eliminating water from the aqueous mixture
to prevent the acids traversing the cell wall. The sonicated mixture
was therefore heated in an oven at 70° until the three parts water
had been removed to form the end product colloidal aggregate.
Example 2
In a further experiment 10% by weight of acid mixture was
mixed with 10% of acid resistant gelatin (Gelatex, Chem. Colloids
Ltd) and 10% water and the mixture was sonicated for 3 minutes
using 20KHz probe (70 Watts) producing proteinaceous colloidal
capsules with particle sizes of less than 100 microns advantageously
between 1 and 20 microns.
The gelatin/water/acid colloid was heated in an oven at 60° for
24 hours to remove the water from the gelatin/water boundary
leaving a gelatin capsule.
It has been found that gelatin capsules of the present invention
of acid mixture have a shelf life of at least 3 months and that upon
heating samples thereof up to 90c in the presence of phenolic resins
a cure is obtained within 5 minutes.
The encapsulation material may take many different forms. For example, a material comprising a combination of gelatin
with xanthan gum has been found to be particularly advantageous
combining longtime resistance to acid attack with ready
encapsulation of acid and rupturing of the encapsulation on
application of an external energy source such as ultrasound.
Preferred formulations of the above ingredients lie in the
following range:-
Xanthan Gum 0.1 - 50.1
Gelatin 99.9 - 49.9
The material is produced by the adhesion, agglomeration and
enrobing of gelatin with xanthan gum. Apart from the above
ingredient combinations, the following ingredients in the following
ingredient combinations may also be used:-
(a) Gelatin 99.9 - 49.9 Gellan Gum 0.1 - 50.1
(b) Gum Arabic 99.9 - 49.9 Xanthan Gum 0.1 - 50.1
(c) Gum Arabic 99.9 - 49.9
Gellan Gum 0.1 - 50.1
(d) Gellatin 99.9 - 49.9 Tragacanth 0.1 - 50.1
(e) Gum Arabic 99.9 - 49.9 Tragacanth 0.1 - 50.1 (f) Gelatin 99.9 - 49.9 Gum Arabic 0.1 - 50.1
(g) Gelatin 99.9 - 49.9 Polyglycol Alginates 0.1 - 50.1
A blend of all the above combinations may also be employed.
In any combination comprising gelatin any of the following may
be employed as alternatives:-
- Hydroiysed Gelatin
Alginates
Carrageenan (Kappa, lota and Lambda)
Locust Bean Gum
Gum Arabic
- High Methoxyl Pectins
Gellan Gum
Methyl Cellulose and Methyl Hydroxpropyl Cellulose
or any mixture/modifications of the above
Agar
In any combination comprising xanthan gum any of the
following may be employed as alternatives: -
Hydroxyethyl Cellulose
Carboxymethyl Cellulose
Gum Arabic Tragacanth
Gellan Gum
Sulphuric Acid Monoesters of Gum Tragacanth
Polyglycol Alginates
- Low Methoxyl Pectins
In the above, the following terms have the following meanings:-
(a) Gelatin and Hydrolysed Gelatin
Protein derived from the hydrolysis of animal collagen
(including fish) or any short chain combination of
constituent amino acids.
(b) Carrageenan and Agar
Products extracted from red seaweed having galatose
backbone joined together by alternating glycosidic
linkages.
(c) Guar. Locust Bean. Tara. Cassia. Mesquite and
Fenugreek gum
Galactomannans - a family of linear polysaccharides
based on a backbone of β(1-4)-linked D-mannose
residues.
(d) Gum Arabic. Gum Tragacanth and Gum Karya Exudate Gums - yielded from species of trees and
shrubs, which first appears as a liquid and is dried in the
sun and air to form a hard glassy lump.
(e) Xanthan and Gellan Gum
Biosynthetic Polysaccharide Gums - produced by
fermentation using specific bacteria.
(f) Alginates and Alginate Esters
Salts of Alginic Acid - with a degree of polymerisation
usually in the range of 100 - 3000 corresponding to
molecular weights of approximately 20,000 - 600,000.
Propylene Glycol Alginate (PGA) is an ester of alginic
acid and propylene glycol.
(g) Methyl Cellulose. Methyl Hydroxpropyl Cellulose.
Hydroxyethyl Cellulose and Carboxymethyl Cellulose
Cellulose Ethers - prepared by reacting cellulose with
caustic to form 'alkali cellulose' which in turn is
alkylated or alkoxylated in the presence or absence of
inert diluent or by Williamson Etherification reaction.
(h) Low Methoxyl Pectins and High Methoxyl Pectins
Pectins - are the partial breakdown products of complex structures in plant cell wall (normally fruits). These can
be modified by de-esterification to produce high
methoxyl and low methoxyl pectins.
The capsules of acid may be mixed with the resin to be cured
by any suitable means. The resins may be phenolic or urea
formaldehyde. The very small size of the capsules facilitates dispersal
in the resin. The mixing process is low energy, low shear to avoid
premature rupturing of the capsules. A suitable form of mixer may
be a paddle mixer. The shelf life of a product comprising resin to be
cured and encapsulated acid may be tailored to a customer's
requirements. Shelf lives of at least three months and possibly of
longer than one year may be achieved.
The capsules dispersed in the resin may be ruptured to release
the acid to initiate curing by any suitable means. Appropriate means
include heating, sound, ultrasound, radio waves, microwaves or
pressure. The latter may be particularly advantageous in the
production of products which inherently involve the application of
pressure such as for example laminated products.
It will be appreciated that the above embodiments have been
described by way of example only and that many variations are
possible without departing from the scope of the invention.

Claims

1 . A colloidal aggregate suitable for use in the curing of resins
comprising a continuous phase of a water based encapsulation
material and a dispersed phase comprising one or more strong acids
wherein the continuous phase may be ruptured by an external energy source to release the acid.
2. A colloidal aggregate as claimed in claim 1 , in which the
encapsulent comprises a water based acid resistant gelatin.
3. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and xanthan gum.
4. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and gellan gum.
5. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and xanthan gum.
6. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and tragacanth.
7. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and tragacanth.
8. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gelatin and gum arabic
9. A colloidal aggregate as claimed in claim 1 or 2, in which the encapsulent comprises a mixture of gelatin and polygiycol alginates.
10. A colloidal aggregate as claimed in claim 1 or 2, in which the
encapsulent comprises a mixture of gum arabic and gellan gum.
11. A colloidal aggregate as claimed in any of claims 3 to 10 in
which the ratio of the two ingredients to each other lie in the ranges
99.9 to 49.9 and 0.1 to 50.1.
12. A colloidal aggregate as claimed in claim 1 , in which the
encapsulent comprises hydrolysed gelatin, alginates, carrageenan
(Kappa, lota and Lambda), locust bean gum, gum arabic, high
methoxyl pectins, gellan gum, methyl cellulose and methyl
hydroxpropyl cellulose or any combination thereof or agar.
13. A colloidal aggregate as claimed in claim 1, in which the
encapsulent comprises xanthan gum combined with one of the
following hydroxyethyl cellulose, carboxymethyl cellulose, gum
arabic, tragacanth, gellan gum, sulphuric acid monoesters of gum
tragacanth, polygiycol alginates, low methoxyl pectins.
14. A colloidal aggregate as claimed in claim 1 or 2, in which the
strong acid comprises sulphuric acid, or hydrochloric acid, or
phosphoric acid, or toluene sulphonic acid or a mixture thereof.
15. A colloidal aggregate in accordance with Example 1 or Example
2.
16. A resin system for the production of rigid articles wherein said
resin systems comprises resin and a dispersed catalyst/initiator said
catalyst/initiator being colloidal aggregate comprising a continuous
phase of a water based encapsulent material and a dispersed phase
comprising one or more strong acids wherein the continuous phase
may be ruptured by an external energy source to release the acid into
the resin and thereby initiating/catalysing the resin curing.
17. A fibrous carrier layer impregnated with a resin system as
claimed in claim 16.
18. A fibrous carrier layer as claimed in claim 17 which is shaped
while uncured.
19. A fibrous carrier layer as claimed in claim 17 or 18 which has
a fibrous sheet structure including a mat, a web or randomly
orientated fibres.
20. A fibrous carrier layer as claimed in claim 19, in which the
fibres are of glass.
21. A method for the microencapsulation of one or more strong
acids suitable for use as catalysts, promoters or initiators in resin
curing reactions, comprising the following steps :-
mixing the acid(s), a water based encapsulent and water,
sonicating the mixture so formed to encapsulate the acid(s) in th e encapsulent, and
substantially removing surplus water from the mixture to form
a colloidal aggregate of the acid in the encapsulent.
22. A method as claimed in claim 21 in which the mixture is
sonicated with ultrasound.
23. A method as claimed in claim 22, in which the mixture is
sonicated with audible sound.
24. A method as claimed in claims 21 , 22 or 23, in which the
capsules formed in the sonification step are heated for a period of
about twenty four hours at a temperature below 80°C.
25. A method as claimed in claim 24 in which the capsules are
heated at a temperature between 60° and 70°C.
PCT/GB1997/003346 1996-12-17 1997-12-16 Encapsulation WO1998026865A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP97949004A EP0948397A1 (en) 1996-12-17 1997-12-16 Encapsulation
CA002275377A CA2275377A1 (en) 1996-12-17 1997-12-16 Encapsulation
AU77366/98A AU727915B2 (en) 1996-12-17 1997-12-16 Encapsulation
JP52742798A JP2001507051A (en) 1996-12-17 1997-12-16 Encapsulation
NO992932A NO992932L (en) 1996-12-17 1999-06-16 encapsulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9626152.4 1996-12-17
GBGB9626152.4A GB9626152D0 (en) 1996-12-17 1996-12-17 Encapsulation

Publications (1)

Publication Number Publication Date
WO1998026865A1 true WO1998026865A1 (en) 1998-06-25

Family

ID=10804552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/003346 WO1998026865A1 (en) 1996-12-17 1997-12-16 Encapsulation

Country Status (8)

Country Link
EP (1) EP0948397A1 (en)
JP (1) JP2001507051A (en)
CN (1) CN1248928A (en)
AU (1) AU727915B2 (en)
CA (1) CA2275377A1 (en)
GB (1) GB9626152D0 (en)
NO (1) NO992932L (en)
WO (1) WO1998026865A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015694A2 (en) * 1998-09-12 2000-03-23 Chemcolloids Limited Curing of resins
WO2010026294A1 (en) * 2008-09-05 2010-03-11 A. Graveolens Oy Composition, process for preparing the composition, and use of the composition
WO2011051033A2 (en) 2009-10-30 2011-05-05 Evonik Röhm Gmbh Encapsulation of reactive components for 1-k systems using coaxial dies
WO2011051034A1 (en) 2009-10-30 2011-05-05 Evonik Röhm Gmbh Reactive 1-component roadway marking
CN112079993A (en) * 2020-09-22 2020-12-15 肇庆市海特复合材料技术研究院 Preparation method of epoxy resin latent curing agent

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005146064A (en) * 2003-11-13 2005-06-09 Konica Minolta Medical & Graphic Inc Dispersion of microcapsuled dye dispersion, its manufacturing process, and photosensitive material for thermal development photography

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179044A1 (en) * 1972-04-03 1973-11-16 Scherer Corp R P
DE3447833A1 (en) * 1984-12-29 1986-07-10 Allan Gerhard 8047 Karlsfeld Frühauf Cloth or the like with microcapsules containing an active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179044A1 (en) * 1972-04-03 1973-11-16 Scherer Corp R P
DE3447833A1 (en) * 1984-12-29 1986-07-10 Allan Gerhard 8047 Karlsfeld Frühauf Cloth or the like with microcapsules containing an active ingredient

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015694A2 (en) * 1998-09-12 2000-03-23 Chemcolloids Limited Curing of resins
WO2000015694A3 (en) * 1998-09-12 2000-07-13 Cehmcolloids Ltd Curing of resins
WO2010026294A1 (en) * 2008-09-05 2010-03-11 A. Graveolens Oy Composition, process for preparing the composition, and use of the composition
WO2011051033A2 (en) 2009-10-30 2011-05-05 Evonik Röhm Gmbh Encapsulation of reactive components for 1-k systems using coaxial dies
WO2011051034A1 (en) 2009-10-30 2011-05-05 Evonik Röhm Gmbh Reactive 1-component roadway marking
DE102009046244A1 (en) 2009-10-30 2011-05-19 Evonik Röhm Gmbh Encapsulation of reactive components for 1-component systems using coaxial nozzles
CN112079993A (en) * 2020-09-22 2020-12-15 肇庆市海特复合材料技术研究院 Preparation method of epoxy resin latent curing agent

Also Published As

Publication number Publication date
CN1248928A (en) 2000-03-29
AU727915B2 (en) 2001-01-04
GB9626152D0 (en) 1997-02-05
NO992932D0 (en) 1999-06-16
CA2275377A1 (en) 1998-06-25
AU7736698A (en) 1998-07-15
NO992932L (en) 1999-08-04
JP2001507051A (en) 2001-05-29
EP0948397A1 (en) 1999-10-13

Similar Documents

Publication Publication Date Title
JP4676625B2 (en) Method for producing water absorbent resin powder
AU727915B2 (en) Encapsulation
Yao et al. Microcapsules/microspheres related to chitosan
EP2066737B1 (en) Method for producing water absorbent resin particle
EP0198089A1 (en) Encapsulated polymer particles and process for their production
CN105924596B (en) A kind of method that fibroin base absorbent material is prepared by grafting vinyl monomers
US20210363329A1 (en) Composite particles, composite-particle composition, and method for producing composite-particle composition
CN104356406B (en) Method for coating polyphenol material with gelatin-polysaccharide graft
Schmieg et al. Development and performance of a 3D‐printable poly (ethylene glycol) diacrylate hydrogel suitable for enzyme entrapment and long‐term biocatalytic applications
EP2283047B1 (en) Filled nanoparticles
CN108607599A (en) A kind of quantum dot-Au/C3N4Hydrogel based photocatalyst
Kim et al. Self-healing starch-based ‘green’thermoset resin
JP3503138B2 (en) Microcapsule wall material, method for forming the same, and microcapsule having the microcapsule wall material
Mala et al. Protection and controlled gastrointestinal release of bromelain by encapsulating in pectin–resistant starch based hydrogel beads
CN114010836B (en) Hemostatic dressing and preparation method thereof
Souzandeh et al. Self-healing of ‘green’thermoset zein resins with irregular shaped waxy maize starch-based/poly (D, L-lactic-co-glycolic acid) microcapsules
JP2001288201A (en) Hydrolysis depolymerization of cellulose ether using acid catalyst
CN110101871B (en) Preparation method of embedded resveratrol
CN101091796A (en) Method for synthesizing lactide copolymer grafted by beta cyclodextrin
JPH0641319A (en) Production of granular hydrous gelatinous polymer and water absorbing resin
AU5870799A (en) Curing of resins
CN105585663A (en) Preparation method and application of glycopolymer
Tay et al. Response Surface Methodology: A Versatile Tool for the Optimization of Particle Sizes of Cellulose Beads.
Torres et al. Production of chemically modified chitosan microspheres by a spraying and coagulation method
Chang et al. Application and prospect of self-healing microcapsules in surface coating of wood

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97181767.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2275377

Country of ref document: CA

Ref document number: 2275377

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 77366/98

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 1998 527427

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997949004

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997949004

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 77366/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09331103

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1997949004

Country of ref document: EP